Scot Randy Weinberger
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$6.9MFederal grants as PI8 awards
6Patents grantedLatest Apr 1, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $6.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 27, 2025 | NIH | SBIR Phase II Multi-Radical Protein Footprinting (MRPF™) Platform | $1.2M | GENNEXT TECHNOLOGIES, INC. |
| May 20, 2024 | NIH | SBIR Phase II Multi-Radical Protein Footprinting (MRPF™) Platform | $1.3M | GENNEXT TECHNOLOGIES, INC. |
| Mar 16, 2023 | NIH | SBIR Phase II Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity | $592K | GENNEXT TECHNOLOGIES, INC. |
| Feb 28, 2023 | NIH | SBIR Phase II In-cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System | $1.2M | GENNEXT TECHNOLOGIES, INC. |
| Mar 2, 2022 | NIH | SBIR Phase II Software for Determining Proteoform Heterogeneity and Protein Expression Fidelity | $643K | GENNEXT TECHNOLOGIES, INC. |
| Jan 26, 2022 | NIH | SBIR Phase II FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis | $471K | GENNEXT TECHNOLOGIES, INC. |
| Jan 26, 2021 | NIH | SBIR Phase II FoxWare™, An Advanced Data Analysis Package for Hydroxyl Radical Foot-Printing Higher Order Structural Analysis | $492K | GENNEXT TECHNOLOGIES, INC. |
| Feb 12, 2020 | NIH | SBIR Phase II Tailoring the Hydroxyl Radical Foot-Printing Approach to Provide a Solution for the Higher Order Structural Analysis Needs of the Biopharmaceutical Industry | $997K | GENNEXT TECHNOLOGIES, INC. |
7 patents as inventor
- US 10816468GENNEXT TECHNOLOGIES, INC.Oct 27, 2020
- US 11181529GENNEXT TECHNOLOGIES, INC.Nov 23, 2021
- US 12013400GENNEXT TECHNOLOGIES, INC.Jun 18, 2024
- US 12013401GENNEXT TECHNOLOGIES, INC.Jun 18, 2024
- US 12016688GENNEXT TECHNOLOGIES, INC.Jun 25, 2024
- US 12263477GENNEXT TECHNOLOGIES, INC.Apr 1, 2025
- US GENNEXT TECHNOLOGIES, INC.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#153
Awards as PI#216
Patents#42
Companies
- GENNEXT TECHNOLOGIES, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.